Corbus Pharmaceuticals Holdings, Inc.

CRBP

Corbus Pharmaceuticals Holdings, Inc.
Current price$5.275
5 days change-4.53%
CRBP intrinsic value

$16.74

+217.37%
Strong SellStrong Buy

Strong Buy

Corbus Pharmaceuticals earnings report beats estimated earnings per share by 666.67%, but misses revenue by Infinity%

Corbus Pharmaceuticals earnings report beats estimated earnings per share by 666.67%, but misses revenue by Infinity%

Corbus Pharmaceuticals reported earnings per share of $0. 03 on revenue of $null, the consensus between analysts was $-0.17 per share on revenue of $10M.

What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update

What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update

The clinical-stage biotech's top- and bottom-line numbers weren't the most important thing in the first quarter.

Corbus Pharmaceuticals (CRBP) to Report Q1 Results: Wall Street Expects Earnings Growth

Corbus Pharmaceuticals (CRBP) to Report Q1 Results: Wall Street Expects Earnings Growth

Corbus Pharmaceuticals (CRBP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.